Cyrus Vahdatpour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cyrus Vahdatpour has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Adam Austin
Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida College of Medicine, Gainesville, Florida, USA
1 shared publication - Christopher Z. Wen
Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA,
1 shared publication Harold Palevksy
Department of Pulmonary Critical Care Medicine, Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States
1 shared publication- Johnny F. Jaber
Univ Florida, Coll Med, Div Pulm Crit Care Sleep Med, 1600 SW Archer Rd, Gainesville, FL 32608 USA
1 shared publication - Joy Ayyoub1 shared publication
- Kathleen Davin1 shared publication
Latest Publications
- Open Access
- 20 September 2024
- Published by Scientific Scholar in American Journal of Interventional Radiology
- Vol. 8, 14
Endovascular treatment and long-term safety for pulmonary artery stenosis due to Takayasu’s arteritis – A case re port
Takayasu’s arteritis is a rare large vessel vasculitis which can involve the pulmonary arteries and progress to pulmonary artery (PA) stenosis with pulmonary hypertension. We present a case of Takayasu arteritis complicated by bilateral pulmonary stenosis and pulmonary hypertension that resolved after PA stenting and angioplasty. This case demonstrates the efficacy of endovascular intervention and sustained safety during 10 years of follow-up.
- 20 September 2024
- Published by Scientific Scholar in American Journal of Interventional Radiology
- Vol. 8, 14
Open AccessEndovascular treatment and long-term safety for pulmonary artery stenosis due to Takayasu’s arteritis – A case re port
Takayasu’s arteritis is a rare large vessel vasculitis which can involve the pulmonary arteries and progress to pulmonary artery (PA) stenosis with pulmonary hypertension. We present a case of Takayasu arteritis complicated by bilateral pulmonary stenosis and pulmonary hypertension that resolved after PA stenting and angioplasty. This case demonstrates the efficacy of endovascular intervention and sustained safety during 10 years of follow-up.
- Open Access
- 13 July 2022
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e26801
Clinical Characteristics and Outcomes of COVID-19 Acute Respiratory Distress Syndrome (ARDS) Survivors in Early Pandemic: A Single Healthcare System Retrospective Study
Introduction: Acute respiratory distress syndrome (ARDS) management in the intensive care unit (ICU) has attracted strong interest since the start of the COVID-19 pandemic. Our retrospective study aims to describe the outcomes and predictors of mortality of ARDS associated with COVID-19 within one university-based healthcare system. Methods: We identified 165 patients within our healthcare system during the months of April 2020 through July 2020, who were admitted to our medical ICUs and eligible for our study. Baseline patient characteristics, ICU and hospital course information, ICU interventions, ventilator settings, and hospital complications were collected and analyzed using descriptive statistical techniques. Results: Our cohort had an average age of 64. No significant difference in mortality was identified with male vs. female gender or BMI. Most of the patient cohort was identified as black (68.2%). The overall mortality of our cohort was 38.2%. Hyperlipidemia, coronary artery disease, and chronic obstructive pulmonary disease were all associated with higher mortality. There was a significant difference in mortality between those with higher observed ventilator plateau pressures at 24 hours and higher driving pressures at 24 hours. Conclusion: COVID-19-associated ARDS is associated with significant mortality. Physicians should be aware of pre-existing conditions potentially related to worse outcomes so that they receive an appropriate level of care in a timely manner. Ventilator management should focus on maintaining low intra-thoracic pressure changes. Prospective studies are needed to guide COVID-19-associated ARDS management.
- 13 July 2022
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e26801
Open AccessClinical Characteristics and Outcomes of COVID-19 Acute Respiratory Distress Syndrome (ARDS) Survivors in Early Pandemic: A Single Healthcare System Retrospective Study
Introduction: Acute respiratory distress syndrome (ARDS) management in the intensive care unit (ICU) has attracted strong interest since the start of the COVID-19 pandemic. Our retrospective study aims to describe the outcomes and predictors of mortality of ARDS associated with COVID-19 within one university-based healthcare system. Methods: We identified 165 patients within our healthcare system during the months of April 2020 through July 2020, who were admitted to our medical ICUs and eligible for our study. Baseline patient characteristics, ICU and hospital course information, ICU interventions, ventilator settings, and hospital complications were collected and analyzed using descriptive statistical techniques. Results: Our cohort had an average age of 64. No significant difference in mortality was identified with male vs. female gender or BMI. Most of the patient cohort was identified as black (68.2%). The overall mortality of our cohort was 38.2%. Hyperlipidemia, coronary artery disease, and chronic obstructive pulmonary disease were all associated with higher mortality. There was a significant difference in mortality between those with higher observed ventilator plateau pressures at 24 hours and higher driving pressures at 24 hours. Conclusion: COVID-19-associated ARDS is associated with significant mortality. Physicians should be aware of pre-existing conditions potentially related to worse outcomes so that they receive an appropriate level of care in a timely manner. Ventilator management should focus on maintaining low intra-thoracic pressure changes. Prospective studies are needed to guide COVID-19-associated ARDS management.